Investors Overview

Investors Overview

Our Mission

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

Learn more about BD

News Releases

09/23/2020

Summary Toggle BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay

FRANKLIN LAKES, N.J. , Sept. 23, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for the use of the

PDF Version
09/21/2020

Summary Toggle BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error

Three Recalls Designated as Class I by FDA; One Designated as Class II FRANKLIN LAKES, N.J. , Sept. 21, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced voluntary recalls of the BD

PDF Version
09/09/2020

Summary Toggle New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims

Results show clinical study design may influence performance estimates and published sensitivity claims of SARS-CoV-2 antigen tests FRANKLIN LAKES, N.J. , Sept. 9, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced the

PDF Version
08/31/2020

Summary Toggle BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J. , Aug. 31, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming virtual investor healthcare conferences: Wells Fargo Securities 2020 Healthcare

PDF Version
08/20/2020

Summary Toggle BD Provides Update on Previously Disclosed Recall of BD Alaris System Hardware

Majority of June 30 Recall Designated as Class I Recall by FDA FRANKLIN LAKES, N.J. , Aug. 20, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced voluntary recall of the BD Alaris™

PDF Version
08/17/2020

Summary Toggle Kristen Stewart to Join BD as Senior Vice President of Strategy and Investor Relations

FRANKLIN LAKES, N.J. , Aug. 17, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Kristen Stewart to the newly created position of senior vice president of Strategy and Investor Relations.

PDF Version